mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.048 |
0.4 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |